Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
+3.73M
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
+$221M
-
Put/Call ratio
-
0.9
-
Number of buys
-
122
-
Number of sells
-
-73
-
Price
-
$59.66
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2024
242 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q3 2024.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 22.3M outstanding shares and own 84.74% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.69M shares), VANGUARD GROUP INC (1.35M shares), GOLDMAN SACHS GROUP INC (716K shares), STATE STREET CORP (704K shares), DIMENSIONAL FUND ADVISORS LP (655K shares), Ranger Investment Management, L.P. (590K shares), Pacer Advisors, Inc. (568K shares), JPMORGAN CHASE & CO (555K shares), Global Alpha Capital Management Ltd. (536K shares), and CITADEL ADVISORS LLC (530K shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.